Arkolith/Insider Trading/FATE/Form 4/A

Redmile Group, LLC

Director, 10% OwnerFATE THERAPEUTICS INC (FATE) · full profile →Form 4/A · filed Apr 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)266K—$00
Apr 20, 2026Other(J)266K—$0503K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-26-047974) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML